Anticancer activity and toxicity profiles of 2-benzylidene indanone lead molecule (original) (raw)

2015, European Journal of Pharmaceutical Sciences

AI-generated Abstract

This study investigates the anticancer activity and toxicity profiles of a novel lead compound, 2-benzylidene indanone, which shows promise as a treatment for various cancers, specifically through its effects on Ehrlich ascites carcinoma. Findings reveal significant tumor growth inhibition at varying dosages, with favorable safety margins observed in toxicity profiles. This research contributes valuable insights into the development of effective anticancer agents derived from natural products.

Sign up for access to the world's latest research.

checkGet notified about relevant papers

checkSave papers to use in your research

checkJoin the discussion with peers

checkTrack your impact